Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Phase II Randomized Controlled Trial Comparing Ultra-Hypofractionated and Moderately Hypofractionated Proton Radiotherapy Following Breast-Conserving Surgery in Early-Stage Breast Cancer（UPH-BC）

NCT07135661 is registered in ClinicalTrials.gov with Shanghai Proton and Heavy Ion Center as lead sponsor.

NCT NCT07135661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Phase II Randomized Controlled Trial Comparing Ultra-Hypofractionated and Moderately Hypofractionated Proton Radiotherapy Following Breast-Conserving Surgery in Early-Stage Breast Cancer（UPH-BC）
Lead sponsor
Shanghai Proton and Heavy Ion Center
Phase
Not applicable
Overall status
Recruiting
Start date
October 10, 2024
Completion date
October 31, 2029
Enrollment
312 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, proton therapy